Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer. A pilot study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples